In a report from the National Institute of Public Health and the Environment in the Netherlands , R-biopharm’s RIDA®GENE SARS-CoV-2 RT-PCR kit, positively identified the highest number of clinical samples.
Considering the findings, they believe that all of the commercially available RT-PCR kits included in this study can be used for routine diagnostics of symptomatic COVID-19 patients. When performing virus diagnostics in populations that may be expected to display low viral loads, such as health-care workers with mild or no symptoms or patients during later stages of the infection , it might be advisable to use those kits that performed best regarding the positive identification of clinical samples.